Allen Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Allen Investment Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,680	Closed	-$939K	–	177
2019 Q3	$939K	Hold	15,680	–	–	0.02%	110
2019 Q2	$1.01M	Hold	15,680	–	–	0.03%	109
2019 Q1	$1.27M	Buy	15,680 +31	+0.2%	+$2K	0.04%	99
2018 Q4	$846K	Hold	15,649	–	–	0.03%	99
2018 Q3	$807K	Hold	15,649	–	–	0.03%	124
2018 Q2	$652K	Hold	15,649	–	–	0.02%	125
2018 Q1	$690K	Sell	15,649 -3	-0%	-$152	0.03%	115
2017 Q4	$787K	Hold	15,652	–	–	0.04%	108
2017 Q3	$794K	Hold	15,652	–	–	0.04%	116
2017 Q2	$796K	Buy	15,652 +6,147	+65%	+$286K	0.04%	118
2017 Q1	$382K	Hold	9,505	–	–	0.02%	180
2016 Q4	$455K	Hold	9,505	–	–	0.03%	152
2016 Q3	$348K	Hold	9,505	–	–	0.02%	171
2016 Q2	$221K	Hold	9,505	–	–	0.02%	198
2016 Q1	$385K	Hold	9,505	–	–	0.03%	151
2015 Q4	$589K	Hold	9,505	–	–	0.05%	114
2015 Q3	$384K	Buy	9,505 +2,391	+34%	+$124K	0.04%	151
2015 Q2	$409K	Hold	7,114	–	–	0.04%	151
2015 Q1	$453K	Hold	7,114	–	–	0.03%	157
2014 Q4	$439K	Buy	+7,114	New	+$351K	0.03%	145

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allen Investment Management's IONS Position: Q4 2019 in Review

Allen Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2019, closing a stake of 15,680 shares — an estimated $939K sold.

Allen Investment Management first reported a position in IONS in Q4 2014 and held it in 20 quarters. The position peaked at $1.27M in Q1 2019. 390 funds tracked by Wall St. Rank hold IONS as of Q4 2019.

Allen Investment Management reported no remaining Ionis Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Allen Investment Management sold 15,680 Ionis Pharmaceuticals shares in Q4 2019, an estimated $939K.
Allen Investment Management first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 20 quarters.
Allen Investment Management's Ionis Pharmaceuticals position peaked at $1.27M in Q1 2019.
390 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2019.

Based on Allen Investment Management's 13F filing for Q4 2019, filed 4 Feb 2020.